<div id="readability-page-1">Charles Schwab’s chief investment strategist Liz Ann Sonders expects the market to continue broadening beyond top performers in 2026. In an interview by CNBC, Sonders noted that while only 17% of S&amp;P 500 (SP500) constituents outperformed the index six months ago, that figure has recently jumped to 61%, signaling improving market breadth. She also h...</div>

KROS

NUTX

INVA

<p>查爾斯·施瓦布的 Liz Ann Sonders 預測，2026 年市場將超越大型股，向更廣泛的領域發展，小型股將顯示出改善。她建議關注小型股中盈利能力強的細分市場，強調 Nutex Health、IRSA、Power Solutions、Amerigo Resources、Innoviva 和 Keros Therapeutics 作為首選。儘管經濟指標放緩，盈利仍在推動市場表現。Sonders 建議選擇性投資於高質量、盈利的股票，以獲得更好的回報</p>

嘉信理財的 Liz Ann Sonders 表示，股票將在 2026 年繼續擴展至大盤股之外